首页> 外文期刊>The FASEB Journal >Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression
【24h】

Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression

机译:酸性鞘磷脂酶通过AKT激活和AMP激活的蛋白激酶抑制作用来调节肝细胞的葡萄糖和脂质代谢

获取原文
获取外文期刊封面目录资料

摘要

Acid sphingomyelinase (ASM) regulates the homeostasis of sphingolipids, including ceramides and sphingosine-1-phosphate (S1P). Because sphingolipids regulate AKT activation, we investigated the role of ASM in hepatic glucose and lipid metabolism. Initially, we overexpressed ASM in the livers of wild-type and diabetic db/db mice by adenovirus vector (Ad5ASM). In these mice, glucose tolerance was improved, and glycogen and lipid accumulation in the liver were increased. Using primary cultured hepatocytes, we confirmed that ASM increased glucose uptake, glycogen deposition, and lipid accumulation through activation of AKT and glycogen synthase kinase-3β. In addition, ASM induced up-regulation of glucose transporter 2 accompanied by suppression of AMP-activated protein kinase (AMPK) phosphorylation. Loss of sphingosine kinase-1 (SphK1) diminished ASM-mediated AKT phosphorylation, but exogenous S1P induced AKT activation in hepatocytes. In contrast, SphK1 deficiency did not affect AMPK activation. These results suggest that the SphK/S1P pathway is required for ASM-mediated AKT activation but not for AMPK inactivation. Finally, we found that treatment with high-dose glucose increased glycogen deposition and lipid accumulation in wild-type hepatocytes but not in ASM?/? cells. This result is consistent with glucose intolerance in ASM?/? mice. In conclusion, ASM modulates AKT activation and AMPK inactivation, thus regulating glucose and lipid metabolism in the liver.—Osawa, Y., Seki, E., Kodama, Y., Suetsugu, A., Miura, K., Adachi, M., Ito, H., Shiratori, Y., Banno, Y., Olefsky, J. M., Nagaki, M., Moriwaki, H., Brenner, D. A., Seishima, M. Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression.
机译:酸性鞘磷脂酶(ASM)调节鞘脂的稳态,包括神经酰胺和鞘氨醇-1-磷酸(S1P)。因为鞘脂调节AKT激活,所以我们研究了ASM在肝葡萄糖和脂质代谢中的作用。最初,我们通过腺病毒载体(Ad5ASM)在野生型和糖尿病db / db小鼠的肝脏中过表达ASM。在这些小鼠中,葡萄糖耐量得到改善,肝脏中的糖原和脂质堆积增加。使用原代培养的肝细胞,我们证实ASM通过激活AKT和糖原合酶激酶3β来增加葡萄糖摄取,糖原沉积和脂质积累。此外,ASM诱导葡萄糖转运蛋白2上调,同时抑制AMP激活的蛋白激酶(AMPK)磷酸化。鞘氨醇激酶1(SphK1)的丢失减少了ASM介导的AKT磷酸化,但外源性S1P诱导了肝细胞中AKT的活化。相反,SphK1缺乏并不影响AMPK激活。这些结果表明,SphK / S1P途径是ASM介导的AKT激活所必需的,而AMPK灭活则不是。最后,我们发现用大剂量葡萄糖处理可增加野生型肝细胞中的糖原沉积和脂质积聚,而不会增加ASMβ/β中的糖原沉积和脂质积聚。细胞。该结果与ASM 3中的葡萄糖不耐症一致。老鼠。总之,ASM调节AKT激活和AMPK失活,从而调节肝脏中的葡萄糖和脂质代谢。-Osawa,Y.,Seki,E.,Kodama,Y.,Suetsugu,A.,Miura,K.,Adachi,M 。,Ito,H.,Shiratori,Y.,Banno,Y.,Olefsky,JM,Nagaki,M.,Moriwaki,H.,Brenner,DA,Seishima,M.酸性鞘磷脂酶通过AKT调节肝细胞中的葡萄糖和脂质代谢激活和AMP激活的蛋白激酶抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号